Stock Market

Moderna Earnings Hit by Falling Covid Vaccine Sales

[ad_1]



Moderna


stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings missed expectations.

The biotech company (ticker: MRNA) reported earnings per share of $3.61 in the fourth quarter on revenue of $5.1 billion.

[ad_2]

Share this news on your Fb,Twitter and Whatsapp

File source

Times News Network:Latest News Headlines
Times News Network||Health||

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close